2P5A1413-square-webb

Annika Berg

Board of Directors since 2020

Education/Background: Annika Carlsson Berg has more than 35 years of experience in the pharmaceutical, biotech, Life Sciences, and diagnostics industries, of which 24 years have been in executive positions. Annika is a regulatory consultant through her own company. Her prior positions were Global Vice President of Quality Assurance & Regulatory Affairs at the Division of Immunodiagnostics at Thermo Fisher Scientific, Global Vice President of Quality Assurance, Regulatory Affairs, and Medical Affairs at Agilent Technologies, Global Vice President of QA/RA at GE Healthcare and Section Manager at Pfizer. Annika is an analytical chemist, and she holds a licentiate’s degree in analytical chemistry

Current Assignments:  Board member at ACB Diagnostics AB/

Holdings:  25,000 TO7 and 25,000 TO10

Some of our Collaborations

>3200

Numbers of patients in studies

24

Publications

10

Pharma Contracts